Abstract LB-056: An integrated genomic, epigenetic, proteomic, and single cell analysis of pediatric B cell acute lymphoblastic leukemia to elucidate resistance mechanisms to CD19 CAR T cell therapy
Katherine E. Masih(National Institutes of Health), Javed Khan(Kent State University), Michael C. Jensen(Seattle Children's Hospital), Rimas J. Orentas(Capital Caring), Michael C. Kelly(National Cancer Institute), Ashley Wilson(Center for Infectious Disease Research), Zachary Rae(National Institutes of Health), Jun S. Wei(Center for Cancer Research), Justin Lack(Office of Extramural Research), Benjamin Z. Stanton(Nationwide Children's Hospital), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Rebecca Gardner(Seattle Children's Hospital), Berkley E. Gryder(University School), Olivia Finney(Seattle Children's Hospital), Sivasish Sindiri(National Institutes of Health), Chaoyu Wang(Chongqing University), Xinyu Wen(National Institutes of Health)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k